Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver

Drug Metabolism and Disposition

Volumn 24, Issue 11, 1996, Pages 1197-1204

  Kocarek, Thomas A ^a   Reddy, Anita B ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NAPHTHOFLAVONE; CIPROFIBRATE; CYTOCHROME P450; DEXAMETHASONE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; MEVINOLIN; PHENOBARBITAL; PRAVASTATIN; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; LIVER MICROSOME; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FATTY ACIDS, MONOUNSATURATED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

ANIMALIA;

EID: 0030457867     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. H. Remmer and H. J. Merker: Drug induced changes in the liver endoplasmatic reticulum: association with drug-metabolizing enzymes. Science (Wash. DC) 142, 1657-1658 (1963).
2. D. M. Heuman, E. J. Gallagher, J. L. Barwick, N. A. Elshourbagy, and P. S. Guzelian: Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16α-carbonitrile or other steroidal or nonsteroidal agents. Mol. Pharmacol. 21, 753-760 (1982).
3. D. E. Ryan, P. E. Thomas, D. Korzeniowski, and W. Levin: Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene treatment. J. Biol. Chem. 254, 1365-1374 (1979).
4. F. P. Guengerich, G. A. Dannan, S. T. Wright, M. V. Martin, and L. S. Kaminsky: Purification and characterization of liver microsomal P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21, 6019-6030 (1982).
5. E. G. Schuetz, S. A. Wrighton, S. H. Safe, and P. S. Guzelian: Regulation of cytochrome P-450p by phenobarbital and phenobarbital-like inducers in adult rat hepatocytes in primary monolayer culture and in vivo. Biochemistry 25, 1124-1133 (1986).
6. K. A. Hostetler, S. A. Wrighton, D. T. Molowa, P. E. Thomas, W. Levin, and P. S. Guzelian: Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Mol. Pharmacol. 35, 279-285 (1989).
7. R. Ramsden, K. M. Sommer, and C. J. Omiecinski: Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J. Biol. Chem. 268, 21722-21726 (1993).
8. A. Shervington, E. A. Shephard, and I. R. Phillips: Identification of DNA sequences involved in the transcription of a CYP2B2 gene. Biochem. Soc. Trans. 22, S121 (1994).
9. E. A. Shephard, L. A. Forrest, A. Shervington, L. M. Fernandez, G. Ciaramella, and I. R. Phillips: Interaction of proteins with a cytochrome P450 2B2 gene promoter: identification of two DNA sequences that bind proteins that are enriched or activated in response to phenobarbital. DNA Cell Biol. 13, 793-804 (1994).
10. E. Trottier, A. Belzil, C. Stoltz, and A. Anderson: Localization of a phenobarbital-responsive element (PBRE) in the 5′-flanking region of the rat CYP2B2 gene. Gene 158, 263-268 (1995).
11. N. Ram, M. V. Rao, L. Prabhu, C. S. Nirodi, S. Sultana, P. G. Vatsala, and G. Padmanaban: Characterization of a negative cis-acting DNA element regulating the transcription of CYP2B1/B2 gene in rat liver. Arch. Biochem. Biophys. 317, 39-45 (1995).
12. L. Prabhu, P. Upadhya, N. Ram, C. S. Nirodi, S. Sultana, P. G. Vatsala, S. A. Mani, P. N. Rangarajan, A. Surolia, and G. Padmanaban: A model for the transcriptional regulation of the CYP2B1/B2 gene in rat liver. Proc. Natl. Acad. Sci. USA 92, 9628-9632 (1995).
13. P. M. Shaw, M. Edigkaufer, J. Doehmer, and M. Adesnik: Sequence of the rat PB-inducible CYP2B1 promoter. Biochim. Biophys. Acta 1305, 54-58 (1996).
14. R. G. Bars, D. R. Bell, and C. R. Elcombe: Induction of cytochrome-P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro. Biochem. Pharmacol. 45, 2045-2053 (1993).
15. S. Green and W. Wahli: Peroxisome proliferator-activated receptors: finding the orphan a home. Mol. Cell. Endocrinol. 100, 149-153 (1994).
16. C. Bocos, M. Gottlicher, K. Gearing, C. Banner, E. Enmark, M. Teboul, A. Crickmore, and J.-A. Gustafsson: Fatty acid activation of peroxisome proliferator activated receptor (PPAR). J. Steroid Biochem. Mol. Biol. 53, 467-473 (1995).
17. T. A. Kocarek, E. G. Schuetz, and P. S. Guzelian: Regulation of phenobarbital-inducible cytochrome-P450 2B1/2 messenger RNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes. Toxicol. Appl. Pharmacol. 120, 298-307 (1993).
18. J. Davignon, M. Xhignesse, H. Mailloux, J. Frohlich, M. L. Hayden, H. Vanetta, M. A. Mishkel, M. J. McQueen, M. H. Tan, B. Wolfe, E. Nikkila, M. J. Tikkanen, J. P. Ojala, E. Helve, C. A. Dujovne, S. Horniman, I. Goldberg, H. Ginsberg, R. Goldberg, R. Farkas, D. Hunninghake, L. Bell, R. Helgren, R. Knopp, B. Mcginnis, P. Kwiterovich, A. Goldberg, A. Bloom, V. Miller, J. Larosa, D. B. Stoy, G. Gasparis, G. Schonfeld, C. Anderson, M. Dillingham, D. Steinberg, J. Witztum, N. Kelly, H. Webb, E. A. Stein, G. E. Lamkin, R. S. Lees, A. M. Lees, S. W. Stein, D. Brennan, D. R. Illingworth, S. R. Bacon, A. M. Gotto, R. H. Jones, J. A. Farmer, C. Payton-Ross, E. B. Feldman, T. T. Kuske, L. C. Davis, P. Samuel, B. Chin, B. H. Schoenfeld, L. Markowski, R. J. Havel, P. H. Frost, P. Tun, N. J. Stone, D. L. Dyer, and L. Richards: Lovastatin 5-year safety and efficacy study. Arch. Intern. Med. 153, 1079-1087 (1993).
19. J. C. Daubresse, G. Debacker, J. Ducobu, C. Harvengt, J. L. Degennes, P. Dousteblazy, M. Farnier, G. Anders, H. G. Dammann, E. Neumann, B. Schwarze, C. Seifart, J. Kastelein, A. Stalenhoef, S. Keidar, A. Capurso, R. Decesaris, G. Descovich, R. Fellin, F. Feruglio, P. Malini, B. Trimarco, R. Scott, A. Marais, U. Keller, T. Moccetti, P. Bloomfield, R. Cramb, E. Hughes, M. Seed, R. Wray, E. Stein, J. Fruchart, A. Sweany, D. Shapiro, and A. Tate: Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. Am. J. Cardiol. 71, 1408-1414 (1993).
20. E. Leitersdorf, S. Eisenberg, O. Eliav, N. Berkman, E. J. Dann, D. Landsberger, E. Sehayek, V. Meiner, T. K. Peters, E. N. Muratti, J. M. Bard, J. C. Fruchart, and Y. Stein: Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia. Eur. J. Clin. Pharmacol. 45, 513-518 (1993).
21. T. A. Kocarek, E. G. Schuetz, S. C. Strom, R. A. Fisher, and P. S. Guzelian: Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metab. Dispos. 23, 415-421 (1995).
22. E. G. Schuetz, J. D. Schuetz, S. C. Strom, M. T. Thompson, R. A. Fisher, D. T. Molowa, D. Li, and P. S. Guzelian: Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18, 1254-1262 (1993).
23. U. Karayalcin, Y. Takeda, I. Miyamori, T. Morise, and R. Takeda: Effect of 3-hydroxy-3-methylglutaryl conzyme A reductase inhibitor pravastatin on urinary 6β-hydroxycortisol excretion: a preliminary study. Steroids 56, 598-600 (1991).
24. Y. Horsmans, J. P. Desager, V. Vandenberge, M. Abrassart, and C. Harvengt: Effects of simvastatin and pravastatin on 6β-hydroxycortisol excretion, a potential marker of cytochrome-P-450-3A. Pharmacol. Res. 28, 243-248 (1993).
25. D. Li, E. G. Schuetz, and P. S. Guzelian: Hepatocyte culture in study of P450 regulation. Methods Enzymol. 206, 335-344 (1991).
26. P. Chomczynski and N. Sacchi: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
27. C. Puissant and L.-M. Houdebine: An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Biotechniques 8, 148-149 (1990).
28. E. G. Schuetz, D. Li, C. J. Omiecinski, U. Muller-Eberhard, H. K. Kleinman, B. Elswick, and P. S. Guzelian: Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J. Cell Physiol. 134, 309-323 (1988).
29. P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk: Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85 (1985).
30. T. A. Kocarek, E. G. Schuetz, and P. S. Guzelian: Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. Mol. Pharmacol. 38, 440-444 (1990).
31. J. S. Sidhu, F. M. Farin, T. J. Kavanagh, and C. J. Omiecinski: Effect of tissue-culture substratum and extracellular matrix overlay on liver-selective and xenobiotic inducible gene expression in primary rat hepatocytes. In Vitro Toxicol. 7, 225-242 (1994).
32. M. S. Brown and J. L. Goldstein: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 21, 505-517 (1980).
33. I. I. Singer, S. Scott, D. M. Kazazis, and J. W. Huff: Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes. Proc. Natl. Acad. Sci. USA 85, 5264-5268 (1988).
34. F. Mercenne, H. Goudonnet, J. Mounie, A. Escousse, and R. C. Truchot: Effects of simvastatin, a lipoprotein-lowering drug, on the hepatic enzymes involved in drug metabolism in the Wistar rat. Xenobiotica 21, 859-864 (1991).
35. M. Charmoillaux, H. Goudonnet, F. Mercenne, J. Mounie, and R. C. Truchot: Comparative and simultaneous effects of simvastatin and ciprofibrate on plasma lipid parameters and upon hepatic drug metabolizing and peroxisome proliferation marker enzymes in the male Wistar rat. Cell Mol. Biol. 37, 765-771 (1991).
36. K. Ziegler, M. Blumrich, and S. Hummelsiep: The transporter for the HMG-CoA reductase inhibitor pravastatin is not present in Hep G2 cells: evidence for the nonidentity of the carrier for pravastatin and certain transport systems for BSP. Biochim. Biophys. Acta 1223, 195-201 (1994).
37. A. Puga, B. Raychaudhuri, and D. W. Nebert: Transcriptional derepression of the murine Cyp1a-1 gene by mevinolin. FASEB J. 6, 777-785 (1992).
38. D. E. Duggan, I. W. Chen, W. F. Bayne, R. A. Halpin, C. A. Duncan, M. S. Schwartz, R. J. Stubbs, and S. Vickers: The physiological disposition of lovastatin. Drug Metab. Dispos. 17, 166-173 (1989).
39. P. A. Todd and K. L. Goa: Simvastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 40, 583-607 (1990).
40. D. McTavish and E. M. Sorkin: Pravastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 42, 65-89 (1991).
41. K. P. Vyas, P. H. Kari, S. M. Pitzenberger, R. A. Halpin, H. G. Ramjit, B. Arison, J. S. Murphy, W. F. Hoffman, M. S. Schwartz, E. H. Ulm, and D. E. Duggan: Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse. Drug Metab. Dispos. 18, 203-211 (1990).
42. K. P. Vyas, P. H. Kari, S. R. Prakash, and D. E. Duggan: Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin. Drug Metab. Dispos. 18, 218-222 (1990).
43. S. Vickers, C. A. Duncan, K. P. Vyas, P. H. Kari, B. Arison, S. R. Prakash, H. G. Ramjit, S. M. Pitzenberger, G. Stokker, and D. E. Duggan: In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. Drug Metab. Dispos. 18, 476-483 (1990).
44. R. W. Wang, P. H. Kari, A. Y. Lu, P. E. Thomas, F. P. Guengerich, and K. P. Vyas: Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes. Arch. Biochem. Biophys. 290, 355-361 (1991).